Award winning cancer research – KIT spin-off amcure GmbH convinces at the CyberOne Award with a new approach for the pancreatic cancer therapy

amcure-Gründer Dr. Matthias Klaften und Dr, Alexandra Matzke

The amcure GmbH in Karlsruhe was awarded with the second place of the Cyber One Award on June 12th, 2012 for its new active substance against pancreatic cancer. Furthermore, the amcure GmbH was awarded the renowned special prize of the state of Baden-Württemberg. The four company founders of the young spin-off of the Karlsruhe Institute of Technology work on the active substance AM001, which could open up new possibilities of treating cancer of the pancreas in the future.

Continue reading